Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion type Assertion NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_head.
- NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion description "[This study was conducted to (a) determine the effect of Cetuximab on invasion and NSCLC-metastasis; (b) investigate urokinase-type plasminogen activator receptor (u-PAR), a major molecule promoting invasion and metastasis, as a target molecule; (c) delineate molecular mediators of Cetuximab-induced metastasis inhibition; and (d) identify biomarkers of drug sensitivity in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_provenance.
- NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion evidence source_evidence_literature NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_provenance.
- NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion SIO_000772 19276367 NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_provenance.
- NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion wasDerivedFrom befree-20140225 NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_provenance.
- NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_assertion wasGeneratedBy ECO_0000203 NP775244.RAD0W16PPHTlLOUeI8Uw2HZUEJTR8jTAgs0nA3YdSQUyI130_provenance.